Your browser doesn't support javascript.
loading
The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation.
Lu, Dong; Nakagawa, Rinako; Lazzaro, Sandra; Staudacher, Philipp; Abreu-Goodger, Cei; Henley, Tom; Boiani, Sara; Leyland, Rebecca; Galloway, Alison; Andrews, Simon; Butcher, Geoffrey; Nutt, Stephen L; Turner, Martin; Vigorito, Elena.
Afiliação
  • Lu D; Lymphocyte Signaling and Development and The Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT, England, UK.
  • Nakagawa R; Lymphocyte Signaling and Development and The Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT, England, UK.
  • Lazzaro S; Lymphocyte Signaling and Development and The Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT, England, UK.
  • Staudacher P; Lymphocyte Signaling and Development and The Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT, England, UK.
  • Abreu-Goodger C; National Laboratory of Genomics for Biodiversity (Langbio), Cinvestav, Irapuato, 36821 Guanajuato, Mexico.
  • Henley T; Lymphocyte Signaling and Development and The Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT, England, UK.
  • Boiani S; Lymphocyte Signaling and Development and The Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT, England, UK.
  • Leyland R; Lymphocyte Signaling and Development and The Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT, England, UK.
  • Galloway A; Lymphocyte Signaling and Development and The Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT, England, UK.
  • Andrews S; Lymphocyte Signaling and Development and The Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT, England, UK.
  • Butcher G; Lymphocyte Signaling and Development and The Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT, England, UK.
  • Nutt SL; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia 3010, Australia Department of Medical Biology, University of Melbourne, Parkville, Victoria 3010, Australia.
  • Turner M; Lymphocyte Signaling and Development and The Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT, England, UK martin.turner@babraham.ac.uk elena.vigorito@babraham.ac.uk.
  • Vigorito E; Lymphocyte Signaling and Development and The Bioinformatics Group, The Babraham Institute, Babraham Research Campus, Cambridge, Cambridgeshire CB22 3AT, England, UK martin.turner@babraham.ac.uk elena.vigorito@babraham.ac.uk.
J Exp Med ; 211(11): 2183-98, 2014 Oct 20.
Article em En | MEDLINE | ID: mdl-25288398
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Diferenciação Celular / Transativadores / Proteínas Proto-Oncogênicas / MicroRNAs / Fator de Transcrição PAX5 Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Diferenciação Celular / Transativadores / Proteínas Proto-Oncogênicas / MicroRNAs / Fator de Transcrição PAX5 Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article